Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter
1998

Cyclin E and p53 in Renal Pelvic and Ureteral Cancer

Sample size: 121 publication Evidence: moderate

Author Information

Author(s): M Furihata, Y Ohtsuki, H Sonobe, T Shuin, A Yamamoto, N Terao, M Kuwahara

Primary Institution: Kochi Medical School

Hypothesis

The study investigates the prognostic significance of cyclin E and p53 protein overexpression in transitional cell carcinoma of the renal pelvis and ureter.

Conclusion

The simultaneous overexpression of cyclin E and p53 is associated with poorer prognosis in patients with transitional cell carcinoma.

Supporting Evidence

  • 29.8% of tumors showed positive immunoreaction with cyclin E antibody.
  • 28.9% of tumors showed positive immunoreaction with p53 antibody.
  • 69.4% of cyclin E-positive tumors also exhibited positive p53 staining.
  • Patients with TCCs coexpressing cyclin E and p53 had significantly poorer prognosis.

Takeaway

This study found that when both cyclin E and p53 proteins are overexpressed in kidney cancer, patients tend to have worse outcomes.

Methodology

Immunohistochemical examination of cyclin E and p53 protein expression in tumor samples from 121 patients.

Limitations

The study is limited to a specific cohort and may not generalize to all populations.

Participant Demographics

121 patients, 84 men and 37 women, ages 45-93 years (mean age 71.4 years).

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication